Maximillian Woodall

University College London — United Kingdom

Medicine · Health Sciences

9h-index760citations35works15.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(9), COVID-19 Clinical Research Studies(8), Cystic Fibrosis Research Advances(7), Respiratory viral infections research(5), Neonatal Respiratory Health Research(4)

Publications34 total

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infection
2026Open Access
Disease ecology and zoonotic risk of clade 2.3.4.4b H5N1 high pathogenicity avian influenza in the sub-Antarctic region
2025· 1 citedOpen Access
Distinctive T-cell receptor repertoire in paediatric inflammatory multisystem syndrome temporally associated with coronavirus disease 2019/multisystem inflammatory syndrome in children patients: possible thymus involvement
Clinical & Experimental Immunology·2025Open Access
Efficient <i>in vitro</i> assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains
Antimicrobial Agents and Chemotherapy·2024· 9 citedOpen Access
S142 Nasal cells from older adults exhibit early pro-fibrotic responses to SARS-CoV-2, which facilitates viral replication and spread
2024
Human SARS-CoV-2 challenge uncovers differences in local and systemic cellular responses associated with protection from infection and distinct infection states
2024
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Nature·2024· 2 citedOpen Access
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Nature·2024· 103 citedOpen Access
Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection
Nature Microbiology·2024· 1 citedOpen Access
Age-specific nasal epithelial responses to SARS-CoV-2 infection
Nature Microbiology·2024· 43 citedOpen Access
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Nature Communications·2024· 38 citedOpen Access
Remdesivir and Nirmatrelvir Show Consistent Synergistic Efficacy Across Ancestral and Newly Emerged Sars-Cov-2 Clinical Isolates
SSRN Electronic Journal·2024Open Access
A one-step method for generating antimicrobial nanofibre meshes <i>via</i> coaxial electrospinning
Materials Advances·2024· 2 citedOpen Access
Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients
Mucosal Immunology·2023· 8 citedOpen Access
Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing
Molecular Therapy — Methods & Clinical Development·2023· 8 citedOpen Access
Expression of gain-of-function CFTR in cystic fibrosis airway cells restores epithelial function better than wild-type or codon-optimized CFTR
Molecular Therapy — Methods & Clinical Development·2023· 9 citedOpen Access
Lung viral infection modelling in a bioengineered whole-organ
Biomaterials·2023· 6 citedOpen Access
Lung viral infection modelling in a bioengineered whole-organ
2023Open Access
The emergence of goblet inflammatory or ITGB6 <sup>hi</sup> nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis
2023· 1 citedOpen Access
Primary_Cell_Raw_Data
Figshare·2023Open Access
page 1 of 2Next →

Frequent Co-authors

Claire M. Smith(20), Samuel Ellis(11), Tereza Masonou(10), Deborah L. Baines(9), Katie‐Marie Case(8), Robert E. Hynds(8), Kaylee B. Worlock(7), Sam M. Janes(7), Marko Nikolić(7), Sarah A. Teichmann(7), Robert Tarran(7), Machaela Palor(7), Timothy D. McHugh(7), Paolo De Coppi(7), Rik G.H. Lindeboom(6), Masahiro Yoshida(6), Krzysztof Polański(6), Puja Mehta(6), Lira Mamanova(6), Liam Bolt(6)